Labhasetwar
Disha V. Labhasetwar, Cincinnati, OH US
Patent application number | Description | Published |
---|---|---|
20150320437 | METHOD OF OPERATING AN ARTICULATING ULTRASONIC SURGICAL INSTRUMENT - An apparatus comprises a body assembly, a shaft, an acoustic waveguide, an articulation section, an end effector, and an articulation drive assembly. The shaft extends distally from the body assembly and defines a longitudinal axis. The acoustic waveguide comprises a flexible portion. The articulation section is coupled with the shaft. A portion of the articulation section encompasses the flexible portion of the waveguide. The articulation section comprises a plurality of body portions aligned along the longitudinal axis and a flexible locking member. The flexible locking member is operable to secure the body portions in relation to each other and in relation to the shaft. The end effector comprises an ultrasonic blade in acoustic communication with the waveguide. The articulation drive assembly is operable to drive articulation of the articulation section to thereby deflect the end effector from the longitudinal axis. | 11-12-2015 |
Disha Vinod Labhasetwar, Solon, OH US
Patent application number | Description | Published |
---|---|---|
20140302249 | COATED FIBERS EXHIBITING BEADS-ON-A-STRING MORPHOLOGY - A method of preparing a fiber with periodically spaced beads includes the steps of: coating a base fiber with a settable coating; thereafter allowing the settable coating to form periodically spaced beads on the base fiber; and stabilizing the periodically spaced beads into periodically spaced beads thus creating a fiber with beads-on-a-string morphology. | 10-09-2014 |
Vinod Labhasetwar, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20150139906 | SURFACE-MODIFIED NANOPARTICLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS AND COMPOSITIONS FOR MAKING SAME - Surface-modified polymeric nanoparticles (NPs), compositions for making them, and their use in drug delivery are disclosed. | 05-21-2015 |
Vinod D. Labhasetwar, Omaha, NE US
Patent application number | Description | Published |
---|---|---|
20080248118 | METHOD AND COMPOSITION FOR INHIBITING REPERFUSION INJURY IN THE BRAIN - The present invention relates to a method for inhibiting reperfusion injury in the brain. The method involve injecting via the carotid artery or jugular vein an antioxidant-loaded nanoparticle. A nanoparticle formulation containing an inert plasticizer is also provided for sustained release of an active agent. | 10-09-2008 |
20100015051 | Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent - The present invention relates to a transferrin-conjugated nanoparticle composition with sustained release characteristics. A method for increasing the efficacy of therapeutic agents and a method for treating cancer using the transferrin-conjugated nanoparticle composition are also provided. | 01-21-2010 |
20100203153 | SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS USING THE SAME - The present invention is a composition composed of a therapeutic agent encapsulated in a copolymer of an N-alkylacrylamide, a vinyl monomer, and a polyethylene glycol (PEG) conjugate and a method for using the same in the treatment or prevention of a disease or condition. | 08-12-2010 |
Vinod D. Labhasetwar, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20130089616 | SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS FOR USING THE SAME - The present invention is a composition composed of a therapeutic agent encapsulated in a copolymer of an N-alkylacrylamide, a vinyl monomer, and a polyethylene glycol (PEG) conjugate and a method for using the same in the treatment or prevention of a disease or condition. | 04-11-2013 |
20140050798 | SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS USING THE SAME - The present invention is a composition composed of a therapeutic agent encapsulated in a copolymer of an N-alkylacrylamide, a vinyl monomer, and a polyethylene glycol (PEG) conjugate and a method for using the same in the treatment or prevention of a disease or condition. | 02-20-2014 |